{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:14:15Z","timestamp":1773976455997,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3718,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1538-7836.2012.04874.x","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:06:36Z","timestamp":1344002796000},"page":"2053-2060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"SHARMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"CHATTERJEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"LICHSTEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"MUKHERJEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0010","unstructured":"Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzma A. National Hospital Discharge Survey: 2007 Summary. National Health Statistic Reports, Number 29, Oct: 2010."},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population\u2010based case\u2010control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo\u2010controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1111\/j.1538-7836.2012.04874.x_bb0035","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ajh.20983","article-title":"Estimated annual numbers of US acute\u2010care hospital patients at risk for venous thromboembolism","volume":"82","author":"Anderson","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta\u2010analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","article-title":"Extended\u2010duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial","volume":"153","author":"Hull","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0055","unstructured":"Rivaroxaban Compares Favorably with Enoxaparin in Preventing Venous Thromboembolism in Acutely Ill Patients Without Showing a Net Clinical Benefit. Washington, DC: American College of Cardiology, 5 April 2011. http:\/\/www.cardiosource.org\/News\u2010Media\/Media\u2010Center\/News\u2010Releases\/2011\/04\/MAGELLAN.aspx; accessed 15 January 2012."},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0060","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short\u2010term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double\u2010blind, randomized controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE\u20102): a randomized double\u2010blind trial","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0075","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0080","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomized trial","volume":"9676","author":"Turpie","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0085","unstructured":"NICE (2010). Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG92FullGuideline.pdf. Accessed 6 July 2010."},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0090","first-page":"343","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"18","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0095","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta\u2010analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0100","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0105","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","article-title":"Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients","volume":"23","author":"Goldhaber","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0110","first-page":"460","article-title":"Indications of low\u2010molecular weight heparins in elderly patients","volume":"21","author":"Manciet","year":"1996","journal-title":"Rev Ge\u2032riatr"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0115","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0120","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1538-7836.2004.00991.x","article-title":"Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score","volume":"2","author":"Zakai","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jclinepi.2005.02.024","article-title":"The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests","volume":"58","author":"Kassa\u00ef","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(03)14149-9","article-title":"Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?","volume":"9383","author":"Lowe","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","article-title":"Antiplatelet Trialists\u2019 Collaboration Collaborative overview of randomised trials of antiplatelet therapy\u2014III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients","volume":"308","year":"1994","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2012.04874.x_bb0145","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"23","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"4 Pt 1","key":"10.1111\/j.1538-7836.2012.04874.x_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-94-4-439","article-title":"Is embolic risk conditioned by location of deep venous thrombosis?","volume":"94","author":"Moser","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(69)90002-6","article-title":"Natural history of postoperative deep vein thrombosis","volume":"2","author":"Kakkar","year":"1969","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0160","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","article-title":"Effect of patient\u2019s sex on risk of recurrent venous thromboembolism: a meta\u2010analysis","volume":"368","author":"McRae","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04874.x_bb0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archinte.165.3.341","article-title":"Efficacy and safety of fixed low\u2010dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial","volume":"165","author":"Kucher","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04874.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:57:50Z","timestamp":1761533870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622064947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1538783622064947"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04874.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04874.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}